With the development of modern molecular biology and gene cloning technologies, gene therapy has great potential for treating severe hyperbilirubinemia due to a severe deficiency or complete loss of UGT1A1 enzyme activity. This evidence concerns the gene UGT1A1 and Hyperbilirubinemia.